HIV-1 uses CD4 as the main receptor and either CCR5 (R5 variants) or CXCR4 (X4 variants) as a coreceptor to enter the host cells. X4 variants are usually seen in the late stage of HIV-1 infection and are related to rapid disease progression. X4 and R5 variants have substantial sequence differences especially at the V3 region. However, the evolution pathways that drive development of X4 variants are unclear. We performed Primer ID deep sequencing using longitudinal plasma samples from the Women’s Interagency HIV Study (WIHS) cohort to study the development of X4 variants.
We identified 23 subtype B HIV-seropositive WIHS participants meeting the following criteria: 1) CD4 T+ cell counts declined from >500 cell//µl to <100 cells/µl; 2) therapy-naïve or on failed therapy with unsuppressed viral load; and 3) plasma samples available biannually during the period of CD4 decline. Multiplexed Primer ID MiSeq sequencing targeted HIV-1 PR, RT, IN and V1/V3 regions on longitudinal specimens. X4 variants were determined by both criteria: 1) Geno2pheno coreceptor algorithm with a false positive rate below 2%, and 2) variants form a distinct lineage.
Seventeen participants (74%) had X4 variants at the last time point when CD4 was <100 cells/µl and 6 (23%) had R5 only viral populations. We sequenced all available longitudinal samples for eight X4 participants and two R5 participants with an average 6.6 biannual time points per participant. Seven of the eight X4 participants (87.5%) did not have X4 variants at baseline but developed X4 viruses as minority variants (mean abundance 21% in the viral population) at a median CD4 count of 538 cells/µL (IQR: 491-655). One participant had X4 variants at baseline with a CD4 count of 759 cells/µL. Three of the eight X4 participants (37.5%) had rapid CD4 decline (>300 cells/µL per year) after emerging of X4 variants and two of six R5 participants (33.3%) had rapid CD4 decline overall (p = 0.57). Phylogenetic analysis showed that X4 variants could emerge from multiple pre-existing lineages with distinct V3 sequence changes (Fig 1). Sequence changes at the V1/V2 region were associated with sequence changes in the V3 region during the development of X4 variants in most X4 participants.
X4 variants can emerge as minor variants early during the course of HIV infection. The co-evolution of the V1/V2 region and V3 region suggests that the compensatory mutations on the V1/V2 regions may be required to develop X4 tropism.